RU2011135741A - Лечение псориаза - Google Patents
Лечение псориаза Download PDFInfo
- Publication number
- RU2011135741A RU2011135741A RU2011135741/15A RU2011135741A RU2011135741A RU 2011135741 A RU2011135741 A RU 2011135741A RU 2011135741/15 A RU2011135741/15 A RU 2011135741/15A RU 2011135741 A RU2011135741 A RU 2011135741A RU 2011135741 A RU2011135741 A RU 2011135741A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- nitric oxide
- aqueous composition
- psoriasis
- composition according
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title claims abstract 11
- 239000000203 mixture Substances 0.000 claims abstract 42
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims abstract 38
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims abstract 8
- 230000015572 biosynthetic process Effects 0.000 claims abstract 7
- 241001465754 Metazoa Species 0.000 claims abstract 6
- 239000003638 chemical reducing agent Substances 0.000 claims abstract 6
- 150000003573 thiols Chemical group 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 3
- 238000004519 manufacturing process Methods 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims abstract 3
- 241000282412 Homo Species 0.000 claims abstract 2
- 230000002378 acidificating effect Effects 0.000 claims abstract 2
- 238000011065 in-situ storage Methods 0.000 claims abstract 2
- 230000000977 initiatory effect Effects 0.000 claims abstract 2
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 claims abstract 2
- 150000002826 nitrites Chemical class 0.000 claims abstract 2
- ICRHORQIUXBEPA-UHFFFAOYSA-N thionitrous acid Chemical compound SN=O ICRHORQIUXBEPA-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000000017 hydrogel Substances 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 abstract 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0901456.4A GB0901456D0 (en) | 2009-01-29 | 2009-01-29 | Treatment of psoriasis |
| GB0901456.4 | 2009-01-29 | ||
| PCT/GB2010/050091 WO2010086637A1 (en) | 2009-01-29 | 2010-01-22 | Treatment of psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2011135741A true RU2011135741A (ru) | 2013-03-10 |
Family
ID=40469254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011135741/15A RU2011135741A (ru) | 2009-01-29 | 2010-01-22 | Лечение псориаза |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110287113A1 (OSRAM) |
| EP (1) | EP2391356A1 (OSRAM) |
| JP (1) | JP2012516315A (OSRAM) |
| KR (1) | KR20110120287A (OSRAM) |
| CN (1) | CN102369004A (OSRAM) |
| AU (1) | AU2010209455A1 (OSRAM) |
| BR (1) | BRPI1007543A2 (OSRAM) |
| CA (1) | CA2750758A1 (OSRAM) |
| GB (1) | GB0901456D0 (OSRAM) |
| RU (1) | RU2011135741A (OSRAM) |
| WO (1) | WO2010086637A1 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2827225C (en) * | 2011-02-25 | 2015-01-13 | University Of Windsor | Apparatus for the controlled release of topical nitric oxide |
| KR20170023776A (ko) | 2014-02-26 | 2017-03-06 | 루마 세러퓨틱스 인코포레이티드 | 자외선 광선 치료 장치들 및 방법들 |
| ITUB20154719A1 (it) * | 2015-10-21 | 2017-04-21 | Glano Tech Ltd | Formulazione per il rilascio di ossido nitrico |
| KR20180134856A (ko) | 2016-02-09 | 2018-12-19 | 루마 세러퓨틱스 인코포레이티드 | 광선요법에 의해 건선을 치료하기 위한 방법, 조성물 및 장치 |
| US10716805B2 (en) * | 2018-03-19 | 2020-07-21 | Glanotech Limited | Formulation for release of nitric oxide |
| EP4233830A3 (en) * | 2019-10-07 | 2023-09-20 | Insense Limited | Composition for delivering nitric oxide to skin |
| GB2588748A (en) * | 2019-10-07 | 2021-05-12 | Insense Ltd | Composition for delivering nitric oxide to skin |
| KR102333779B1 (ko) * | 2020-02-03 | 2021-12-03 | 주식회사 큐라젠 | 산화질소 플라즈마를 이용한 돌출형 폴리우레탄 드레싱폼 및 그 제조 방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4305881C1 (de) * | 1993-02-26 | 1994-03-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, welche Stichoxid-Quellen darstellen, Verfahren zu seiner Herstellung sowie seine Verwendung |
| US7052711B2 (en) * | 1999-09-02 | 2006-05-30 | Rice University | Nitric oxide-producing hydrogel materials |
| JP2004503624A (ja) | 2000-06-15 | 2004-02-05 | ファースト ウォーター リミテッド | ヒドロゲル組成物の製造方法ならびに前記製造方法によって製造されたヒドロゲル組成物 |
| GB0021317D0 (en) * | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
| DE60306134T2 (de) | 2002-04-24 | 2007-04-19 | Insense Ltd., Sharnbrook | Wundauflage enthaltend ein oxidoreduktase-enzym in hydratiertem zustand |
| US20040062793A1 (en) * | 2002-07-05 | 2004-04-01 | Dyke Mark Van | Tissue defect dressings comprising proteinaceous networks |
| US20070059351A1 (en) * | 2003-10-17 | 2007-03-15 | Murrell George A C | Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods |
| EP1846009A2 (en) * | 2005-02-11 | 2007-10-24 | NOLabs AB | Improved device for application of medicaments, manufacturing method therefor, and method of treatment |
| EP1861130B1 (en) * | 2005-02-11 | 2008-09-10 | NOLabs AB | Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| EP1690558A1 (en) * | 2005-02-11 | 2006-08-16 | NOLabs AB | Device for treatment of diabetic disorders |
| GB0505035D0 (en) * | 2005-03-11 | 2005-04-20 | Insense Ltd | Improvements relating to skin dressings |
| EP1704876A1 (en) * | 2005-03-24 | 2006-09-27 | NOLabs AB | Cosmetic treatment, device for performing said treatment and manufacturing method thereof |
| GB0616350D0 (en) * | 2006-08-17 | 2006-09-27 | Univ St Andrews | Adsorption and release of nitric oxide in metal organic frameworks |
| US20080206364A1 (en) * | 2006-10-13 | 2008-08-28 | Nitric Biotherapeutics, Inc. | Topical nitric oxide as a treatment of autoimmune diseases |
| GB0715554D0 (en) | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
-
2009
- 2009-01-29 GB GBGB0901456.4A patent/GB0901456D0/en not_active Ceased
-
2010
- 2010-01-22 RU RU2011135741/15A patent/RU2011135741A/ru not_active Application Discontinuation
- 2010-01-22 AU AU2010209455A patent/AU2010209455A1/en not_active Abandoned
- 2010-01-22 BR BRPI1007543A patent/BRPI1007543A2/pt not_active IP Right Cessation
- 2010-01-22 CN CN2010800142892A patent/CN102369004A/zh active Pending
- 2010-01-22 KR KR1020117018765A patent/KR20110120287A/ko not_active Withdrawn
- 2010-01-22 WO PCT/GB2010/050091 patent/WO2010086637A1/en not_active Ceased
- 2010-01-22 EP EP10702163A patent/EP2391356A1/en not_active Withdrawn
- 2010-01-22 US US13/146,725 patent/US20110287113A1/en not_active Abandoned
- 2010-01-22 CA CA2750758A patent/CA2750758A1/en not_active Abandoned
- 2010-01-22 JP JP2011546961A patent/JP2012516315A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010086637A1 (en) | 2010-08-05 |
| EP2391356A1 (en) | 2011-12-07 |
| US20110287113A1 (en) | 2011-11-24 |
| CA2750758A1 (en) | 2010-08-05 |
| KR20110120287A (ko) | 2011-11-03 |
| JP2012516315A (ja) | 2012-07-19 |
| AU2010209455A1 (en) | 2011-08-18 |
| GB0901456D0 (en) | 2009-03-11 |
| CN102369004A (zh) | 2012-03-07 |
| BRPI1007543A2 (pt) | 2016-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123249T1 (el) | Μεθοδοι και συνθεσεις για τη θεραπευτικη αντιμετωπιση δερματικων παθησεων που σχετιζονται με αγγειακη υπερδραστικοτητα | |
| BR112012006891A2 (pt) | formulação de hydrogel compreendendo uma solução aquosa com potencial oxidativo redutivo | |
| JP2012516315A5 (OSRAM) | ||
| ATE495767T1 (de) | Regelungsverfahren für die eluierung von therapeutischen wirkstoffen | |
| MX375287B (es) | Método de tratamiento de un sustrato animal. | |
| CL2008003088A1 (es) | Metodo de preparacion de la sal de de maleato de (e)-n-{4-[3-cloro-4-(2-piridinilmetoxi)anilino]-3-ciano-7-etoxi-6-quinolinil}-4-(dimetilanino)-2-butenamida; formas cristalinas anhidra y monohidrato de la sal maleato; metodo de preparacion; composicion farmaceutica; utiles en el tratamiento de cancer. | |
| WO2009134967A3 (en) | Use of nucleic acids with reduced pressure therapy for treating wounds | |
| CY1117547T1 (el) | Ενωση πυραζολοκινολινης | |
| ATE539721T1 (de) | Vorrichtung zur wundbehandlung | |
| PH12019501469A1 (en) | Compositions and methods for treating biofilms | |
| DE602004017720D1 (de) | Bausatz, vorrichtung und verfahren zur gesteuerten abgabe eines oxidationsmittels in die haut | |
| EP4249431A3 (en) | Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions | |
| EP2133044A3 (de) | Wirkstoffbeladenes Implantat | |
| RU2014150505A (ru) | Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды | |
| WO2010031777A3 (en) | Device and method for regenerative therapy by high intensity laser therapy | |
| DE602004031782D1 (de) | Verfahren zur verwendung regenerativer zellen zur förderung der wundheilung | |
| AR044315A1 (es) | Agente para prevenir y/o tratar enfermedades acompañadas de alteraciones de tejidos que comprende un polipeptido | |
| EP1844779A3 (de) | Tergurid/Protergurid zur Behandlung von chronischen Schmerzen (z.B. Migräne) | |
| WO2019099860A3 (en) | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing | |
| EA201390487A1 (ru) | Антимикробный белок | |
| MX2019003751A (es) | Proteina terapeutica. | |
| MX2023013070A (es) | Formulaciones liquidas ionicas para el tratamiento de enfermedades inflamatorias y autoinmunes. | |
| DE60325965D1 (de) | Für die behandlung bzw. prevention von schmerzen geeignete triazaspiroverbindungen | |
| EA201991530A1 (ru) | Композиции и способы лечения биопленок | |
| WO2006053788A3 (en) | Alterations in seborrheic keratoses and their applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20141118 |